Efficacy and Safety of Penpulimab Combined With Anlotinib and Chemotherapy
Status:
RECRUITING
Trial end date:
2036-04-01
Target enrollment:
Participant gender:
Summary
This study is a two arm, randomized, prospective, multicenter study on the perioperative treatment of locally advanced resectable esophageal cancer with penpulimab combined with anlotinib hydrochloride and chemotherapy.